Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Sex difference in cell proliferation in developing rat amygdala mediated by endocannabinoids has implications for social behavior.

Krebs-Kraft DL, Hill MN, Hillard CJ, McCarthy MM.

Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20535-40. doi: 10.1073/pnas.1005003107. Epub 2010 Nov 8.

2.
3.

Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats.

Trezza V, Damsteegt R, Manduca A, Petrosino S, Van Kerkhof LW, Pasterkamp RJ, Zhou Y, Campolongo P, Cuomo V, Di Marzo V, Vanderschuren LJ.

J Neurosci. 2012 Oct 24;32(43):14899-908. doi: 10.1523/JNEUROSCI.0114-12.2012.

4.

Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala.

Serrano A, Rivera P, Pavon FJ, Decara J, Suárez J, Rodriguez de Fonseca F, Parsons LH.

Alcohol Clin Exp Res. 2012 Jun;36(6):984-94. doi: 10.1111/j.1530-0277.2011.01686.x. Epub 2011 Dec 5.

5.

Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.

Castelli MP, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Gessa GL, Maccarrone M, Pistis M.

Eur J Pharmacol. 2007 Nov 14;573(1-3):11-9. Epub 2007 Jul 4.

PMID:
17644084
6.

Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.

Accorsi-Mendonça D, Almado CE, Dagostin AL, Machado BH, Leão RM.

Brain Res. 2008 Mar 20;1200:1-9. doi: 10.1016/j.brainres.2008.01.011. Epub 2008 Jan 16.

PMID:
18308297
7.

Cannabinoid self-administration in rats: sex differences and the influence of ovarian function.

Fattore L, Spano MS, Altea S, Angius F, Fadda P, Fratta W.

Br J Pharmacol. 2007 Nov;152(5):795-804. Epub 2007 Sep 24.

8.
9.

Modulation of paraoxon toxicity by the cannabinoid receptor agonist WIN 55,212-2.

Nallapaneni A, Liu J, Karanth S, Pope C.

Toxicology. 2006 Oct 3;227(1-2):173-83. Epub 2006 Aug 5.

PMID:
16956707
10.

Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia.

Connell K, Bolton N, Olsen D, Piomelli D, Hohmann AG.

Neurosci Lett. 2006 Apr 24;397(3):180-4. Epub 2005 Dec 27.

PMID:
16378681
11.

Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission.

Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF.

J Neurosci. 2001 Dec 1;21(23):9506-18.

12.

The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.

Luca T, Di Benedetto G, Scuderi MR, Palumbo M, Clementi S, Bernardini R, Cantarella G.

Eur J Pharmacol. 2009 Aug 15;616(1-3):16-21. doi: 10.1016/j.ejphar.2009.06.004. Epub 2009 Jun 17.

PMID:
19539619
13.

Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.

De Petrocellis L, Ligresti A, Moriello AS, Allarà M, Bisogno T, Petrosino S, Stott CG, Di Marzo V.

Br J Pharmacol. 2011 Aug;163(7):1479-94. doi: 10.1111/j.1476-5381.2010.01166.x.

14.

Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus.

Yoshida T, Uchigashima M, Yamasaki M, Katona I, Yamazaki M, Sakimura K, Kano M, Yoshioka M, Watanabe M.

Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3059-64. doi: 10.1073/pnas.1012875108. Epub 2011 Jan 31.

15.

Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.

Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V.

J Pharmacol Exp Ther. 2006 Mar;316(3):969-82. Epub 2005 Nov 11.

16.
17.

Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats.

Rivera P, Luque-Rojas MJ, Pastor A, Blanco E, Pavón FJ, Serrano A, Crespillo A, Vida M, Grondona JM, Cifuentes M, Bermúdez-Silva FJ, de la Torre R, de Fonseca FR, Suárez J.

Eur J Neurosci. 2013 Jan;37(1):105-17. doi: 10.1111/ejn.12012. Epub 2012 Oct 4.

PMID:
23033907
18.

Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.

Guindon J, Guijarro A, Piomelli D, Hohmann AG.

Br J Pharmacol. 2011 Aug;163(7):1464-78. doi: 10.1111/j.1476-5381.2010.01192.x.

19.

Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse.

Kushmerick C, Price GD, Taschenberger H, Puente N, Renden R, Wadiche JI, Duvoisin RM, Grandes P, von Gersdorff H.

J Neurosci. 2004 Jun 30;24(26):5955-65.

20.

Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development.

Galve-Roperh I, Aguado T, Rueda D, Velasco G, Guzmán M.

Curr Pharm Des. 2006;12(18):2319-25. Review.

PMID:
16787257
Items per page

Supplemental Content

Write to the Help Desk